235 related articles for article (PubMed ID: 22573603)
1. In vitro metabolism studies on mephedrone and analysis of forensic cases.
Pedersen AJ; Reitzel LA; Johansen SS; Linnet K
Drug Test Anal; 2013 Jun; 5(6):430-8. PubMed ID: 22573603
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometric evaluation of mephedrone in vivo human metabolism: identification of phase I and phase II metabolites, including a novel succinyl conjugate.
Pozo ÓJ; Ibáñez M; Sancho JV; Lahoz-Beneytez J; Farré M; Papaseit E; de la Torre R; Hernández F
Drug Metab Dispos; 2015 Feb; 43(2):248-57. PubMed ID: 25468950
[TBL] [Abstract][Full Text] [Related]
3. Mephedrone (methylmethcathinone) in toxicology casework: a Northern Ireland perspective.
Cosbey SH; Peters KL; Quinn A; Bentley A
J Anal Toxicol; 2013 Mar; 37(2):74-82. PubMed ID: 23354334
[TBL] [Abstract][Full Text] [Related]
4. Stability of mephedrone and five of its phase I metabolites in human whole blood.
Czerwinska J; Parkin MC; Dargan PI; George C; Kicman AT; Abbate V
Drug Test Anal; 2019 Apr; 11(4):586-594. PubMed ID: 30341975
[TBL] [Abstract][Full Text] [Related]
5. Study of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples.
Grafinger KE; Hädener M; König S; Weinmann W
Drug Test Anal; 2018 Mar; 10(3):562-574. PubMed ID: 28677880
[TBL] [Abstract][Full Text] [Related]
6. Excretion of mephedrone and its phase I metabolites in urine after a controlled intranasal administration to healthy human volunteers.
Czerwinska J; Parkin MC; George C; Kicman AT; Dargan PI; Abbate V
Drug Test Anal; 2022 Apr; 14(4):741-746. PubMed ID: 34984836
[TBL] [Abstract][Full Text] [Related]
7. Screening of stimulants including designer drugs in urine using a liquid chromatography tandem mass spectrometry system.
O'Byrne PM; Kavanagh PV; McNamara SM; Stokes SM
J Anal Toxicol; 2013 Mar; 37(2):64-73. PubMed ID: 23316030
[TBL] [Abstract][Full Text] [Related]
8. Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry.
Meyer MR; Wilhelm J; Peters FT; Maurer HH
Anal Bioanal Chem; 2010 Jun; 397(3):1225-33. PubMed ID: 20333362
[TBL] [Abstract][Full Text] [Related]
9. Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines - an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam and nitrazolam.
Moosmann B; Bisel P; Franz F; Huppertz LM; Auwärter V
J Mass Spectrom; 2016 Nov; 51(11):1080-1089. PubMed ID: 27535017
[TBL] [Abstract][Full Text] [Related]
10. [Mephedrone -- an old-new drug of abuse].
Tóth AR; Hideg Z; Institóris L
Orv Hetil; 2011 Jul; 152(30):1192-6. PubMed ID: 21733792
[TBL] [Abstract][Full Text] [Related]
11. Studies on the metabolism of the fentanyl-derived designer drug butyrfentanyl in human in vitro liver preparations and authentic human samples using liquid chromatography-high resolution mass spectrometry (LC-HRMS).
Steuer AE; Williner E; Staeheli SN; Kraemer T
Drug Test Anal; 2017 Jul; 9(7):1085-1092. PubMed ID: 27736030
[TBL] [Abstract][Full Text] [Related]
12. Detection of mephedrone and its metabolites in fingerprints from a controlled human administration study by liquid chromatography-tandem mass spectrometry and paper spray-mass spectrometry.
Czerwinska J; Jang M; Costa C; Parkin MC; George C; Kicman AT; Bailey MJ; Dargan PI; Abbate V
Analyst; 2020 Apr; 145(8):3038-3048. PubMed ID: 32134419
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of analytically confirmed 3-MMC-related intoxications from the Swedish STRIDA project.
Bäckberg M; Lindeman E; Beck O; Helander A
Clin Toxicol (Phila); 2015 Jan; 53(1):46-53. PubMed ID: 25422862
[TBL] [Abstract][Full Text] [Related]
14. Mephedrone Concentrations in Cases of Clinical Intoxication.
Papaseit E; Olesti E; de la Torre R; Torrens M; Farre M
Curr Pharm Des; 2017; 23(36):5511-5522. PubMed ID: 28677506
[TBL] [Abstract][Full Text] [Related]
15. Determination of a newly encountered designer drug "p-methoxyethylamphetamine" and its metabolites in human urine and blood.
Zaitsu K; Katagi M; Kamata T; Kamata H; Shima N; Tsuchihashi H; Hayashi T; Kuroki H; Matoba R
Forensic Sci Int; 2008 May; 177(1):77-84. PubMed ID: 18155375
[TBL] [Abstract][Full Text] [Related]
16. In vitro metabolism and pharmacokinetic studies on methylone.
Pedersen AJ; Petersen TH; Linnet K
Drug Metab Dispos; 2013 Jun; 41(6):1247-55. PubMed ID: 23545806
[TBL] [Abstract][Full Text] [Related]
17. Studies on the metabolism and detectability of the designer drug β-naphyrone in rat urine using GC-MS and LC-HR-MS/MS.
Meyer MR; Prosser D; Maurer HH
Drug Test Anal; 2013 Apr; 5(4):259-65. PubMed ID: 23303532
[TBL] [Abstract][Full Text] [Related]
18. Evidence of 2 Populations of Mephedrone Abusers by Hair Testing. Application to 4 Forensic Expertises.
Kintz P
Curr Neuropharmacol; 2017; 15(5):658-662. PubMed ID: 27784226
[TBL] [Abstract][Full Text] [Related]
19. Toxicological findings in a fatal multidrug intoxication involving mephedrone.
Gerace E; Petrarulo M; Bison F; Salomone A; Vincenti M
Forensic Sci Int; 2014 Oct; 243():68-73. PubMed ID: 24846124
[TBL] [Abstract][Full Text] [Related]
20. GC-MS Quantification Method for Mephedrone in Plasma and Urine: Application to Human Pharmacokinetics.
Olesti E; Pujadas M; Papaseit E; Pérez-Mañá C; Pozo ÓJ; Farré M; de la Torre R
J Anal Toxicol; 2017 Mar; 41(2):100-106. PubMed ID: 27798075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
